Role of single‐nucleotide polymorphism microarray in the classification of <scp>BAP1</scp>‐inactivated melanocytic tumours
While most BIMs appear to have a favourable prognosis, even those with multiple CNAs, they deserve careful integration of all clinical and pathologic findings. Although not fully diagnostic, a mitotic count of ≥3/mm<sup>2</sup> and ≥6 CNAs in the appropriate context is supportive of a diagnosis of BAP1-inactivated melanoma.
Authors
- Joseph S. Durgin (ORCID: https://orcid.org/0000-0002-1114-817X)
- Rajiv M. Patel (ORCID: https://orcid.org/0000-0002-1521-4947)
- Douglas R. Fullen (ORCID: https://orcid.org/0000-0002-2524-4509)
- Taylor Novice (ORCID: https://orcid.org/0000-0002-9896-2894)
- Aleodor A. Andea (ORCID: https://orcid.org/0000-0003-0874-5616)
- Paul W. Harms (ORCID: https://orcid.org/0000-0002-0802-2883)
- Scott C. Bresler (ORCID: https://orcid.org/0000-0003-2504-466X)
- Alexandra C. Hristov (ORCID: https://orcid.org/0000-0002-1836-6591)
- Lori Lowe (ORCID: https://orcid.org/0000-0002-2359-8426)
- Nicholas A. Zoumberos (ORCID: https://orcid.org/0000-0003-4590-8146)
Institutions
- University of Arkansas at Little Rock (US)
- Roswell Park Comprehensive Cancer Center (US)
- University of Michigan (US)
Publication Details
- Journal
- Histopathology
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1111/his.15434
- Citations
- 4
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 4.18
Funders
- National Institutes of Health